Hot Topics

Poll

Why is it a big mistake to link funding of R&D costs with drug prices?:

WIPO norm-setting on IP and genetic resources: will impasse on mandatory disclosure and the nature of instrument be resolved?

It is crunch time for WIPO's Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore (IGC). The 26th session meets from 3-7 February 2014 in Geneva. This week's session will focus on setting international norms for the protection of genetic resources against misappropriation and resolving two key areas of divergence: 1) the nature of the instrument and 2) the disclosure of origin requirement.

UPDATED- SCP20: Current state of play as countries clash on patents and health (WIPO Standing Committee on the Law of Patents)

On Friday, 31 January 2014 (6:30 PM Geneva time) the WIPO Standing Committee on the Law of Patents (SCP) resumed in plenary mode to discuss the facilitator's text (Mr. Victor Portelli, Australia) on the future work of this committee including activities on 1) Exceptions and Limitations to Patent Rights, 2) Quality of Patents, including Opposition Systems, 3) Patents and Health, 4 Confidentiality of communications between clients and their patent advisors and 5) Transfer of Technology.

SCP20: Kenyan intervention on Patents and Health

20TH Session of the Standing Committee on the Law of Patents

Statement by Kenya

Agenda Item No. 8: Patents and Health, 28th January 2014

Thank you Mr. Chairman for giving Kenya the floor.

Kenya supports the statement made by Algeria on behalf of the African Group and the proposal put forward by the Group and the DAG.

KEI Intervention at WIPO's SCP 20 on Patents and Health

KEI Intervention at SCP20 on Patents and Health

28 January 2014

Thank you Chair.

Intervention of India at EB134 expressing solidarity with the Republic of South Africa in light of Pharmagate

During heated discussions on the topic of access to essential medicines at the 134th session of the World Health Organization's Executive Board, India delivered the following statement on Thursday, 23 January 2014 expressing solidarity with the Republic of South Africa in light of the Pharmagate exposé.

SCP20: Opening statement of the European Union at WIPO's Standing Committee on the Law of Patents, 27 January 2014

On 27 January 2014, Greece, on behalf of the European Union, delivered this opening statement at the 20th session of WIPO Standing Committee on the Law of Patents (SCP). The EU's priorities for WIPO's patent committee include quality of patents (including opposition systems), work sharing and confidentiality of communication between client and their patent advisors.

With respect to limitations and exceptions to patent rights, the EU said,

Intervention of the South Centre at EB134 expressing solidarity with the Republic of South Africa (English translation)

This is the English translation of the intervention delivered by the South Centre on Thursday, 23 January 2014 at the 134th session of the World Health Organization's Executive Board expressing solidarity with the Government of the Republic of South Africa following the Pharmagate exposé.

Thank you, Madam President, for giving us the floor.

HAI and Medicus Mundi statements at WHO EB on CEWG demonstration projects

Three NGOs, Medicus Mundi International, HAI and MSF, each read statements during the EB discussions on the CEWG demonstration projects. The statements were limited to 300 words, and NGOs were required to provide the text 24 hours before the agenda item, and obtain WHO approval of the content. KEI worked with HAI on its statement, and the Peoples Health Movement worked with MMI on its statement. The text of the HAI and MMI statements follow:

Health Action International (HAI) statement to EB 134 On agenda item 9.3, follow up to CEWG on financing and coordination

EB134: Statement of South Africa on Access to Essential Medicines (in the wake of Pharmagate)

On Thursday, 23 January 2014, Malebona Precious Matsoso (Director General of the South African National Department of Health) delivered the the following intervention at the 134th session of the World Health Organization's Executive Board under agenda item 9.7 on Access to essential medicines in response to the recent Pharmagate imbroglio.

Intervention of the South Centre at EB134 expressing solidarity with the Republic of South Africa

On Thursday, 23 January 2014, the South Centre delivered the following statement at the 134th session of the World Health Organization's Executive Board under agenda item 9.7, access to essential medicines, expressing solidarity with the Government of the Republic of South Africa following the Pharmagate exposé.

GRACIAS SENORA PRESIDENTA POR DARNOS LA PALABRA.

Blogs and Press coverage of Pharma/Medicine device industry lobbying on South Africa patent reform (pharmagate)

Boseley, Sarah. 17 January 2014. "South African pharma firms accused of planning to delay patents law reform." The Guardian. http://www.theguardian.com/world/2014/jan/17/south-african-pharma-accuse...

De Wet, Phillip. 17 January 2014. "Motsoaledi: Big pharma's 'satanic' plot is genocide." Mail & Guardian. http://mg.co.za/article/2014-01-16-motsoaledi-big-pharmas-satanic-plot-i...

Bayer CEO Marijn Dekkers explains: Nexavar cancer drug is for "western patients who can afford it.”

dr-dekkers_280_en.jpg
Bayer CEO Marijn Dekkers called the Nexavar compulsory license “essentially theft.”

[UPDATE: The latest blog and transcript of Bayer CEO Marijn Dekkers' full quote on the Indian compulsory license of Nexavar at the December Financial Times event is now available.]

New leaked Merck missive reveals deep drug, medical device company opposition to South African patent reforms

James K Glassman
James K. Glassman. Merck said Glassman's public relations firm was selected by PhRMA to lead a campaign to keep drug prices high in South Africa. The Health Minister in South Africa referred to the campaign proposal as a genocidal conspiracy of satanic magnitude.

KEI testimony on WIPO broadcasting treaty, to House Judiciary Subcommittee on Courts, Intellectual Property, and Internet

Testimony of James Packard Love
Hearing on: The Scope of Copyright Protection
January 14, 2014
Subcommittee on Courts, Intellectual Property, and the Internet

My 10 page written statement is here: http://keionline.org/sites/default/files/JamesLove_Testimony.pdf

My 5 minute oral statement follows:

James Packard Love, Opening statement

Hearing on: The Scope of Copyright Protection
January 14, 2014
Subcommittee on Courts, Intellectual Property, and the Internet

WIPO hosts Conference on Open Innovation: Collaborative Projects and the Future of Knowledge (22-23 January 2014)

The World Intellectual Property Organization (WIPO) will host a "Conference on Open Innovation: Collaborative Projects and the Future of Knowledge" on 22-23 January 2014 at its headquarters in Geneva, Switzerland.

The origins of this conference on open collaborative development models is predicated upon Recommendation 36 of the WIPO Development Agenda which states:

Syndicate content